Antibacterial Drugs Market

Antibacterial Drugs Market (Drug Class - B - lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Sulfonamide, and Phenicols; Routes of Administration - Enteral and Parenteral; Distribution Channel - Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Rep Id : TMRGL1567
  • Published On : Dec 2017
  • No. of Pages : 189
  • Category : Pharmaceutical

Chapter 1. Preface
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights
1.3. Assumptions and Acronyms Used

Chapter 2. Research Methodology 

Chapter 3. Executive Summary 

Chapter 4. Market Overview
4.1. Product Overview
4.2. Key Industry Developments 
4.3. Market Dynamics 
       4.3.1. Drivers
       4.3.2. Restraints
       4.3.3. Opportunity Analysis
       4.3.4. Porter’s Five Forces Representation
       4.3.5. Antibacterial Drugs Market- Value Chain Analysis & Supply-Demand Scenario
       4.3.6. Antibacterial Drugs Market Outlook
       4.3.7. Anti-Bacterial Drugs Pipeline Analysis 

Chapter 5. Global Antibacterial Drugs Market Analysis, by Drug Class, 2015 – 2025
5.1. Key Findings
5.2. Definition
5.3. Introduction
5.4. Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
5.5. Global Antibacterial Drugs Market Analysis, by Drug Class
       5.5.1. β-lactam 
       5.5.2. Quinolones
       5.5.3. Macrolides
       5.5.4. Tetracycline
       5.5.5. Aminoglycoside
       5.5.6. Sulfonamide
       5.5.7. Phenicols
       5.5.8. Others
5.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class
5.7. Global Antibacterial Drugs Market Forecast, by Drug Class
5.8. Key Trends

Chapter 6. Global Antibacterial Drugs Market Analysis, by Routes of Administration 
6.1. Key Findings
6.2. Definitions
6.3. Introduction
6.4. Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
6.5. Global Antibacterial Drugs Market Analysis, by Routes of Administration
       6.5.1. Enteral
       6.5.2. Parenteral
       6.5.3. Others 
6.6. Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration
6.7. Global Antibacterial Drugs Market Forecast, by Routes of Administration

Chapter 7. Global Antibacterial Drugs Market Analysis, by Channels of Distribution 
7.1. Key Findings
7.2. Definitions
7.3. Introduction 
7.4. Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
7.5. Global Antibacterial Drugs Market Analysis, by Channels of Distribution
       7.5.1. Hospital Pharmacies
       7.5.2. Drug Stores & Retail Pharmacies
       7.5.3. Online Sales
7.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution
7.7. Global Antibacterial Drugs Market Forecast, by Channels of Distribution
7.8. Key Trends

Chapter 8. Global Antibacterial Drugs Market Analysis, by Region
8.1. Key Findings 
8.2. Introduction
8.3. Global Antibacterial Drugs Market Value Share Analysis, by Region, 2016 and 2025
8.4. Global Antibacterial Drugs Market Attractiveness Analysis, by Region, 2016
8.5. Global Antibacterial Drugs Market Forecast, by Region, 2015–2025

Chapter 9. North America Antibacterial Drugs Market Analysis
9.1. North America Antibacterial Drugs Market Overview
9.2. North America Antibacterial Drugs Market Forecast, Country wise, 2015–2025
9.3. North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
9.4. North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
9.5. North America Antibacterial Drugs Market Forecast, by Drug Class, 2015–2025
9.6. North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
9.7. North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
9.8. North America Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2025
9.9. North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
9.10. North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
9.11. North America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2025
9.12. Key Trends

Chapter 10. Europe Antibacterial Drugs Market Analysis
10.1. Europe Antibacterial Drugs Market Overview
10.2. Europe Antibacterial Drugs Market Forecast, Country wise, 2015–2025
10.3. Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
10.4. Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
10.5. Europe Antibacterial Drugs Market Forecast, by Drug Class, 2015–2025
10.6. Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
10.7. Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
10.8. Europe Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2025
10.9. Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
10.10. Europe Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
10.11. Europe Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2025
10.12. Key Trends

Chapter 11. Asia Pacific Antibacterial Drugs Market Analysis
11.1. Asia Pacific Antibacterial Drugs Market Overview
11.2. Asia Pacific Antibacterial Drugs Market Forecast, Country wise, 2015–2025
11.3. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
11.4. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
11.5. Asia Pacific Antibacterial Drugs Market Forecast, by Drug Class, 2015–2025
11.6. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
11.7. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
11.8. Asia Pacific Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2025
11.9. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
11.10. Pacific Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
11.11. Asia Pacific Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2025
11.12. Key Trends

Chapter 12. Latin America Antibacterial Drugs Market Analysis
12.1. Latin America Antibacterial Drugs Market Overview
12.2. Latin America Antibacterial Drugs Market Forecast, Country wise, 2015–2025
12.3. Latin America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
12.4. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
12.5. Latin America Antibacterial Drugs Market Forecast, by Drug Class, 2015–2025
12.6. Latin America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
12.7. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
12.8. Latin America Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2025
12.9. Latin America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
12.10. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
12.11. Latin America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2025
12.12. Key Trends

Chapter 13. Middle East & Africa Antibacterial Drugs Market Analysis
13.1. Middle East & Africa  Antibacterial Drugs Market Overview
13.2. Middle East & Africa  Antibacterial Drugs Market Forecast, Country wise, 2015–2025
13.3. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
13.4. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
13.5. Middle East & Africa Antibacterial Drugs Market Forecast, by Drug Class, 2015–2025
13.6. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
13.7. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
13.8. Middle East & Africa Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2025
13.9. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
13.10. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
13.11. Middle East & Africa Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2025
13.12. Key Trends

Chapter 14. Competition Landscape
14.1. Leading Antibacterial Drugs Sales Analysis, 2014 – 2016 
14.2. Competition Matrix
14.3. Company Profiles 
       14.3.1. Bayer AG
                 14.3.1.1. Company Description
                 14.3.1.2. Business Overview
                 14.3.1.3. SWOT Analysis
                 14.3.1.4. Strategic Overview
       14.3.2. Pfizer Inc.
                 14.3.2.1. Company Description
                 14.3.2.2. Business Overview
                 14.3.2.3. SWOT Analysis
                 14.3.2.4. Strategic Overview
       14.3.3. Sanofi
                 14.3.3.1. Company Description
                 14.3.3.2. Business Overview
                 14.3.3.3. SWOT Analysis
                 14.3.3.4. Strategic Overview
       14.3.4. GlaxoSmithKline plc
                 14.3.4.1. Company Description
                 14.3.4.2. Business Overview
                 14.3.4.3. SWOT Analysis
                 14.3.4.4. Strategic Overview
       14.3.5. Merck & Co., Inc
                 14.3.5.1. Company Description
                 14.3.5.2. Business Overview
                 14.3.5.3. SWOT Analysis
                 14.3.5.4. Strategic Overview
       14.3.6. AstraZeneca
                 14.3.6.1. Company Description
                 14.3.6.2. Business Overview
                 14.3.6.3. SWOT Analysis
                 14.3.6.4. Strategic Overview
       14.3.7. Johnson and Johnson
                 14.3.7.1. Company Description
                 14.3.7.2. Business Overview
                 14.3.7.3. SWOT Analysis
                 14.3.7.4. Strategic Overview
       14.3.8. Bristol-Myers Squibb Company
                 14.3.8.1. Company Description
                 14.3.8.2. Business Overview
                 14.3.8.3. SWOT Analysis
                 14.3.8.4. Strategic Overview
       14.3.9. Novartis AG
                 14.3.9.1. Company Description
                 14.3.9.2. Business Overview
                 14.3.9.3. SWOT Analysis
                 14.3.9.4. Strategic Overview
       14.3.10. Allergen Plc.
                 14.3.10.1. Company Description
                 14.3.10.2. Business Overview
                 14.3.10.3. SWOT Analysis
                 14.3.10.4. Strategic Overview

 

List of Tables

Table 01: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 02: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 03: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
Table 04: Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015–2025
Table 06: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 07: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 08: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distributions, 2015–2025
Table 09: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015–2025
Table 10: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 11: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 12: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
Table 13: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015–2025
Table 14: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 15: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 16: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
Table 17: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2015–2025
Table 18: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 19: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 20: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
Table 21: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2015–2025
Table 22: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 23: MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
Table 24: MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025

 

List of Figures

Figure 01: Global Antibacterial Drugs Market Size ($ Mn) and Distribution by Geography, 2017 and 2025
Figure 02: Global Antibacterial Drugs Market Revenue (US$ Mn) and top 3 trends  
Figure 03: Global Antibacterial Drugs Market, by Channels of Distribution, Revenue (US$ Mn) and Market Share
Figure 04: Market Value Share By Drug Class (2017) Revenue (US$ Mn)
Figure 05: Market Value Share By Region (2017) Revenue (US$ Mn)
Figure 06: Antibacterial Drugs in Clinical Trials 
Figure 07: Anti-bacterial Drugs by Indication
Figure 08: Anti-bacterial Drugs by class
Figure 09: Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 10: Global β-lactam Market Revenue (US$ Mn) and Y-o-Y Growth (%), by β-lactam, 2015–2025
Figure 11: Global Quinolones Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 12: Global Macrolides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 13: Global Tetracyclines Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 14: Global Aminoglycosides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 15: Global Sulfonamides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 16: Global Phenicols Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 17: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 18: Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
Figure 19: Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
Figure 20: Global Enteral Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global Parenteral Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: Global Others routes of administration Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 23: Global Antibacterial Drugs Market Attractiveness Analysis, by Routes od Administration, 2016
Figure 24: Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
Figure 25: Global Hospital Pharmacies Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 26: Global Drug Stores & Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 27: Global Online Sales Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 28: Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
Figure 29: Global Antibacterial Drugs Market Value Share Analysis, by Region, 2016 and 2025
Figure 30: Global Antibacterial Drugs Market Attractiveness Analysis, by Region, 2016
Figure 31: North America Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015–2025
Figure 32: North America Antibacterial Drugs Market Y-o-Y Growth Projections, 2015–2025
Figure 33: North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 34: North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
Figure 35: North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
Figure 36: North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
Figure 37: North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
Figure 38: North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
Figure 39: Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015–2025
Figure 40: Europe Antibacterial Drugs Market Y-o-Y Growth Projections, 2015–2025
Figure 41: Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 42: Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
Figure 43: Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
Figure 44: Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
Figure 45: Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
Figure 46: Europe Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
Figure 47: Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015–2025
Figure 48: Asia Pacific Antibacterial Drugs Market Y-o-Y Growth Projections, 2017–2025
Figure 49: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 50: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
Figure 51: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
Figure 52: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
Figure 53: Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
Figure 54: Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
Figure 55: Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015–2025
Figure 56: Latin America Antibacterial Drugs Market, Y-o-Y Growth Projection, 2015–2025
Figure 57: Latin America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 58: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
Figure 59: Latin America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
Figure 60: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
Figure 61: Latin America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
Figure 62: Latin America Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
Figure 63: Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015–2025
Figure 64: Middle East & Africa Antibacterial Drugs Market Y-o-Y Growth Projections, 2015–2025
Figure 65: Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
Figure 66: Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
Figure 67: MEA Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
Figure 68: MEA Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
Figure 69: MEA Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
Figure 70: MEA Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
Figure 71: Leading Antibacterial Drugs Sales Analysis, 2014 – 2016 
Figure 72: Bayer AG, Breakdown of Net Sales, by Region, 2016
Figure 73: Bayer AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 74: Pfizer, Breakdown of Net Sales, by Region, 2016
Figure 75: Pfizer, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 76: Sanofi, Breakdown of Net Sales, by Region, 2016
Figure 77: Sanofi, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 78: GlaxoSmithKline, Breakdown of Net Sales, by Region, 2016
Figure 79: GlaxoSmithKline, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 80: Merck & Co., Breakdown of Net Sales, by Region, 2016
Figure 81: Merck & Co., Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 82: AstraZeneca, Breakdown of Net Sales, by Region, 2016
Figure 83: AstraZeneca, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 84: Johnson & Johnson, Breakdown of Net Sales, by Region, 2016
Figure 85: Johnson & Johnson, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 86: Bristol-Myers Squibb Company, Breakdown of Net Sales, by Region (2016)
Figure 87: Bristol-Myers Squibb Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 88: Novartis AG, Breakdown of Net Sales, by Region, 2016
Figure 89: Novartis AG, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 90: Allergen, Breakdown of Net Sales (%), by Segments (2016)
Figure 91: Allergen, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016